Trials / Terminated
TerminatedNCT02968160
A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Yuhan Corporation · Industry
- Sex
- All
- Age
- 19 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
This is a Randomized, open-label, 2 groups, parallel design.
Detailed description
This study objective is to compare the safety and efficacy between fixed dose combination (Duowell® tab) and free pill combination therapy of Telmisartan and Rosuvastatin in hypertensive and hypercholesterolemic patients with metabolic syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Telmisartan 40mg + Rosuvastatin 20mg | |
| DRUG | Telmisartan 80mg + Rosuvastatin 20mg | |
| DRUG | Telmisartan 40mg, 80 mg | |
| DRUG | Rosuvastatin 20mg |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-02-01
- Completion
- 2018-02-01
- First posted
- 2016-11-18
- Last updated
- 2019-04-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02968160. Inclusion in this directory is not an endorsement.